Endo, Impax Face Yet Another Suit Over Opana Pay-For-Delay
Endo Pharmaceuticals Inc. and Impax Laboratories Inc. were hit with a putative antitrust class action in an Illinois federal court Monday, in which a direct purchaser accuses Endo of paying Impax...To view the full article, register now.
Already a subscriber? Click here to view full article